Drug Trial Radar · NCT00242775
Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg
Last checked: Nov 20, 2026Latest source record: Jan 24, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,100
Actual
Start
May 2005
Primary completion
Not stated
Study completion May 2006
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Oct 21, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the efficacy and safety of a variable dose of Symbicort with a high fixed maintenance dose of another asthma medication, Seretide, in the treatment of asthma.
Conditions
- Asthma
Interventions
Budesonide/formoterol TurbuhalerDrug
Salmeterol/fluticasone DiskusDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to first severe asthma exacerbation
Locations
143 sites in 17 countries. Site status is shown where the registry gives one.
Research Site
Buenos Aires, Argentina
Research Site
San Miguel de Tucumán, Argentina
Research Site
Mar del Plata, Buenos Aires, Argentina
Research Site
Monte Grande, Buenos Aires, Argentina
Research Site
Córdoba, Córdoba Province, Argentina
Research Site
Santa Fe, Santa Fe Province, Argentina
Research Site
San Miguel de Tucumán, Tucumán Province, Argentina
Research Site
Bankstown, New South Wales, Australia
Research Site
Sydney, New South Wales, Australia
Research Site
Westmead, New South Wales, Australia
Research Site
Bundaberg, Queensland, Australia
Research Site
Carina Heights, Queensland, Australia
Research Site
Mackay, Queensland, Australia
Research Site
Ashford, South Australia, Australia
Research Site
Toorak Gardens, South Australia, Australia
Research Site
Woodville South, South Australia, Australia
Research Site
Box Hill, Victoria, Australia
Research Site
Malvern, Victoria, Australia
Research Site
Prahran, Victoria, Australia
Research Site
Rosebud, Victoria, Australia
Research Site
Nedlands, Western Australia, Australia
Research Site
Curitiba, Brazil
Research Site
São Paulo, Brazil
Research Site
Salvador, Estado de Bahia, Brazil
Research Site
Juiz de Fora, Minas Gerais, Brazil
Research Site
Recife, Pernambuco, Brazil
Research Site
Rio de Janeiro, Rio de Janeiro, Brazil
Research Site
Florianópolis, Santa Catarina, Brazil
Research Site
São Paulo, São Paulo, Brazil
Research Site
Edmonton, Alberta, Canada
Research Site
Winnipeg, Manitoba, Canada
Research Site
Mount Pearl, Newfoundland and Labrador, Canada
Research Site
Hamilton, Ontario, Canada
Research Site
London, Ontario, Canada
Research Site
Mississauga, Ontario, Canada
Research Site
North York, Ontario, Canada
Research Site
Ottawa, Ontario, Canada
Research Site
Toronto, Ontario, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Québec, Quebec, Canada
Showing 40 of 143 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.